WIll be a few years before those other product come to market, if they ever do. UATG has a penchant for stopping development of proposed products quietly...
MOST OTC have a product. How those sales equate to revs, is there dilution, are there bad debt deals, is management scummy, is the COMPANY for real - not as simple as having real products.
Curious to see if this plays out differently than most OTC.